Anthony Derek Sung MD
Hematologic Oncology
Medical Instructor, Hematologic Malignancies and Cellular Therapy, Duke University Medical Center
Join to View Full Profile
2650 Shawnee Mission PkwyWestwood, KS 66205
Phone+1 913-945-6674
Dr. Sung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2011 - 2014
Johns Hopkins UniversityInternship, Internal Medicine, 2008 - 2011
Harvard Medical SchoolClass of 2008
Certifications & Licensure
MO State Medical License 2024 - 2026
KS State Medical License 2024 - 2025
NC State Medical License 2014 - 2025
American Board of Internal Medicine Hematology
Clinical Trials
- MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2021 Sep 01
- ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients Start of enrollment: 2020 Oct 14
- Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 Start of enrollment: 2014 Sep 03
Roles: Sub-Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- Measured resting energy expenditure in cardiothoracic surgery patients and changes throughout hospitalization: A descriptive cohort study.Hilary M Winthrop, Megan Beyer, Paul E Wischmeyer, Anthony D Sung, Jeroen Molinger
Clinical Nutrition ESPEN. 2025-04-01 - 1 citationsIbrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis.Joseph Pidala, Jongphil Kim, Denise Kalos, Corey Cutler, Zachariah DeFilipp
Blood Advances. 2025-03-11 - Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.Steven J Siegel, Susan DeWolf, Joseph Schmalz, Wael Saber, Jiayi Dong
Medrxiv. 2025-02-26
Press Mentions
KU-Led Multicenter Trial to Address Food Insecurity and Malnutrition in Cancer PatientsJanuary 13th, 2025- More Options for People with Blood CancersMay 10th, 2023
- FDA Panel Says Poziotinib’s Benefits Don’t Outweigh Risks in NSCLC With HER2 Exon 20 MutationsSeptember 22nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
